BALEZENTIS CARL W 4
4 · ENZO BIOCHEM INC · Filed Dec 20, 2010
Insider Transaction Report
Form 4
BALEZENTIS CARL W
Pres., Enzo Life Sciences,Inc.
Transactions
- Sale
Common Stock, par value $0.01
2010-12-15$5.12/sh−12,724$65,147→ 25,950 total
Footnotes (1)
- [F1]Includes 4,783 shares of the Company's common stock, par value $0.01 per share, held in the Company's 401(k) plan.